Visiongain Publishes Anti-infective Vaccines Market Report 2021-2031
04 June 2021
Visiongain has launched a new report Anti-infective Vaccines Market Report 2021-2031: Forecasts by Product Type (Live/Attenuated Vaccines, Inactivated Vaccines, DNA & Recombinant Vector Vaccines, Others), by Disease Type (Bacterial Diseases (Typhoid Vaccines, Tuberculosis Vaccines, Tetanus & Diphtheria Vaccines, Others), Viral Diseases (Influenza Vaccines, Hepatitis Vaccines, Polio Vaccines, Others)), by Distribution Channel (Hospitals, Clinics, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Anti-infective Vaccines Companies AND COVID-19 Recovery Scenarios.
Global Anti-Infective Vaccines Market Outlook
According to Visiongain analysis, global anti-infective vaccines market was valued at US$xx billion in 2020. The global market is expected to reach US$xx billion in 2026 from its previous value of US$xx billion in 2021. Visiongain further anticipates that the worldwide anti-infective vaccines market will reach US$xx billion in 2031.
Rising R&D Activities to Fuel Anti-Infective Vaccines Market Growth Through 2031
The rising frequency of bacterial and viral diseases coupled with increased focus on immunisation programmes are two main reasons that are expected to boost the global anti-infective vaccines market's growth in the coming years. Furthermore, rising firm activities to improve vaccine research and development, as well as increased government backing for vaccine development, are expected to propel the global anti-infective vaccines market forward in the coming years. The increasing number of prospects from developing economies is expected to boost the total market's growth in the near future.
COVID-19 Impact Analysis on Anti-Infective Vaccines Market
The COVID-19 pandemic has had a negative influence on the global market for anti-infective vaccines. This pandemic has impeded the manufacture and delivery of anti-infective vaccines as a result of the COVID-19 outbreak, which has resulted in stringent border controls, stock market instability, and country-wide lockdowns. Companies are concerned about the COVID-19 epidemic's supply and demand mismatches. All of these changes are having a detrimental impact on the market for anti-infective vaccines, leading industry and regulators to rethink pharmaceutical supply chains.
Key Questions Answered by this Report:
• What is the current size of the overall global anti-infective vaccines market? How much will this market be worth from 2021 to 2031?
• What are the main drivers and restraints that will shape the overall anti-infective vaccines market over the next ten years?
• What are the main segments within the overall anti-infective vaccines market?
• How much will each of these segments be worth for the period 2021 to 2031?
• How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world anti-infective vaccines?
• What is their current status and how will they develop over the next ten years?
• What are their revenue potentials to 2031?
• How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
• Who are the leading companies and what are their activities, results, developments and prospects?
• What are some of the most prominent anti-infective vaccines currently in development?
• What are the main trends that will affect the world anti-infective vaccines market between 2021 and 2031?
• What are the main strengths, weaknesses, opportunities and threats for the market?
• What are the social, technological, economic and political influences that will shape that industry over the next ten years?
• How will the global anti-infective vaccines market evolve over the forecasted period, 2021 to 2031?
• What will be the main commercial drivers for the market from 2021 to 2031?
• How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?
• How will that industry evolve between 2021 and 2031, especially in R&D?
Discover sales predictions for the global anti-infective vaccines market and submarkets
Along with revenue prediction for the overall world market, there are 3 segmentations of the anti-infective vaccines market, with forecasts for 4 Product Types, 2 Disease Type, 4 Distribution Channel each forecasted at a global, regional, and country level, along with COVID-19 impact recovery pattern analysis for all segments.
Who are the leading players analysed in the market?
• Bavarian Nordic
• Berna Biotech Pharma GmbH
• CSL Limited (Seqirus)
• Emergent BioSolutions Inc.
• GlaxoSmithKline plc.
• Hookipa Pharma Inc.
• Merck & Co, Inc.
• Mitsubishi Tanabe Pharma Corporation
• Serum Institute of India Pvt. Ltd.
• Sinovac Biotech Ltd.
• Syneos Health
• Valneva SE
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033
The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.
20 March 2023
Visiongain Publishes eClinical Solutions Market Report 2023-2033
The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.
17 March 2023
Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033
The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
15 March 2023
Visiongain Publishes Regenerative Medicine Market Report 2023-2033
The global Regenerative Medicine market was valued at US$ 50.37 billion in 2022 and is projected to grow at a CAGR of 18.40% during the forecast period 2023-2033.